The International Agency for Research on Cancer (IARC) has finalised its evaluation of possible links between two ‘forever chemicals’ and cancer in ...

Autologous hematopoietic cell transplantation (auto-HCT) resulted in lower relapse rates and improved rates of survival without disease progression compared ...

Enlarged spleen is a common symptom of myelofibrosis, but a new regimen of navitoclax and Jakafi may help, recent findings showed.The combination of ...

Orca-T, a type of blood cancer therapy that is made of donor stem and immune cells, led to promising rates of relapse-free survival (RFS; time after ...

Yescarta boosted survival in patients with pretreated large B-cell lymphoma, research showed. Yescarta (axicabtagene ciloleucel) showed an improvement in ...

An artificial intelligence (AI) platform that analyzed bone marrow biopsies and digital disease images was able to differentiate cases of prefibrotic ...

If you would like this piece read to you, just click above Once covid had really started, and we received our daily dose of Boris Johnson and his clowns ...

Abecma improved multiple quality of life aspects in patients with pretreated myeloma, research showed.Abecma (idecabtagene vicleucel) significantly improved ...

Treatment with Brukinsa (zanubrutinib) led to better progression-free survival (PFS; time from treatment until disease worsening or death) compared with ...

Safety and efficacy of Tecvayli for patients with relapsed/refractory multiple myeloma tended to be similar in the real-world setting as it was in the phase ...

Patients with early-stage breast cancer tended to experience event-free survival benefits with Keytruda plus chemothearpy.Patients with high-risk, ...

Tecartus was safe and effective in a real-world population of patients with high-risk, relapsed/refractory mantle cell lymphoma.For patients with ...